EUCTR2004-002977-22-IT进行中（未招募）不适用
A PHASE II STUDY OF VELCADE BORTEZOMIB - PS341 IN THE TREATMENT OF PATIENTS OVER 18 YEARS WITH Ph LEUKEMIA
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点开始时间: 2007年2月14日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A phase II Study of Bortezomib (Velcade), a proteasome Inhibitor, in treating patients with idiopathic Myelofibrosis (IM) randomized to receive new investigational drugs. - NDMedDRA version: 6.1Level: PTClassification code 10028537idiopathic myelofibrosisEUCTR2006-001462-16-ITOSPEDALE POLICLINICO S. MATTEO35
进行中（未招募）
不适用
PHASE II TRIAL OF BORTEZOMIB (VELCADE) IN COMBINATION WITH CHLORAMBUCIL IN PATIENTS WITH RELAPSED/REFRACTORY WALDENSTROM?S MACROGLOBULINEMIA OR SMALL LYMPHOCYTIC LYMPHOMA. A MULTICENTER STUDY. - NDWALDENSTROM?S MACROGLOBULINEMIA OR SMALL LYMPHOCYTIC LYMPHOMAMedDRA version: 9.1Level: LLTClassification code 10003908Term: B-cell small lymphocytic lymphomaEUCTR2006-003495-35-ITISTITUTO EUROPEO DI ONCOLOGIA
进行中（未招募）
不适用
IFM2013-04Young untreated patients with Multiple myelomaEUCTR2013-003174-27-FRCHU de Nantes
进行中（未招募）
1 期
PHASE II TRIAL OF BORTEZOMIB (VELCADE®) IN PATIENTS WITH ADVANCED OR RELAPSED LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT)EUCTR2005-003077-25-ATAKH Vienna16
已完成
不适用
Bortezomib for children with acute lymphoblastic leukemia (ALL) without other treatment options.acute lymphoblastic leukemiarelapserefractorychildrenNL-OMON23341Erasmus MC, Rotterdam, Netherlands24